Shopping Cart
- Remove All
- Your shopping cart is currently empty
LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $327 | 6-8 weeks | |
25 mg | $767 | 6-8 weeks | |
50 mg | $997 | 6-8 weeks | |
100 mg | $1,750 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $358 | 6-8 weeks |
Description | LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR). |
In vitro | LUF6000 converted a nucleoside A3 AR antagonist MRS542, but not a non-nucleoside antagonist MRS1220, into an agonist. LUF6000 exerted an Emax-enhancing effect at a concentration of 0.1 microM or higher and was shown to increase the Emax of Cl-IB-MECA and other low-efficacy agonists to a larger extent than that of the high-efficacy agonist NECA. A3 adenosine receptor LUF6000 was found to be an allosteric enhancer of Emax of structurally diverse agonists at the A3 AR, being more effective for low-Emax agonists than for high-Emax agonists. |
Molecular Weight | 411.33 |
Formula | C22H20Cl2N4 |
Cas No. | 890087-21-5 |
Relative Density. | 1.401 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 14.29 mg/mL (34.74 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.